ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

Similar documents
For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: LUAVPP (Carboplatin Option)

ABOUT THIS MEDICATION

For the Patient: LUSCTOP

For the Patient: ULUAVPMTN

For the Patient: LUAVPG

For the Patient: LUAJPC

For the Patient: LUAVNP

For the Patient: Eribulin Other names: HALAVEN

For the Patient: LUAVPEM

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: Mitoxantrone Other names:

For the Patient: Trastuzumab emtansine Other names: KADCYLA

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: LUSCPE

For the Patient: LUAVPP

For the Patient: Methotrexate Other names: MTX

For the Patient: LUPUPE

For the Patient: Paclitaxel Other names: TAXOL

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: GDP-R Other names: LYGDPR

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: GOOVDDCAT

For the Patient: GOOVCATM

For the Patient: GOOVCATR

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Sunitinib Other names: SUTENT

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: Cobimetinib tablets Other names: COTELLIC

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

For the Patient: Lenalidomide Other names: REVLIMID

ABOUT THIS MEDICATION

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

ABOUT THIS MEDICATION

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: LULAPERT

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: SAAJAP

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

ABOUT THIS MEDICATION

For the Patient: GOCXCATB

For the Patient: LUAVDC

For the Patient: LUSCCAV

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: UMYLDREL

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

For the Patient: GUBEP

For the Patient: LUOTPAC

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: ACTW Other names: BRAJACTW

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

Treatment Plan: Drugs:

For the Patient: USMAVFIPI

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

For the Patient: Vemurafenib Other names: ZELBORAF

ABOUT THIS MEDICATION

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

For the Patient: USMAVPEM

For the Patient: USMAVNIV

For the Patient: GUPDOCADT

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

For the Patient: ULUAVPMB

ABOUT THIS MEDICATION

For the Patient: ACD

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

ABOUT THIS MEDICATION

For the Patient: CAP. Capecitabine. Uses:

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

ABOUT THIS MEDICATION

Transcription:

For the Patient: HNNAVGEM Treatment of Recurrent or Metastatic Nasopharyngeal Cancer with Gemcitabine HN = Head and Neck N = Nasopharyngeal AV = Advanced GEM = Gemcitabine ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer. How does this drug work? Gemcitabine interferes with the genetic material (DNA and RNA) of cancer cells to prevent their growth. The result is the cancer cell dies. INTENDED BENEFITS This treatment is being given to destroy and/or prevent the growth of cancer cells in your body. This treatment may improve your current symptoms, and delay or prevent the onset of new symptoms. This treatment is meant to control the disease and allow you to live longer after receiving chemotherapy treatment. HNNAVGEM TREATMENT SUMMARY How are these drugs given? Gemcitabine is given intravenously on day 1 and day 8 every 3 weeks. Each cycle is 21 days and may be repeated as long as there is benefit. What will happen when I get my drugs? A blood test is done within one month prior to starting your first treatment. A blood test is done before day 1 and day 8 of each cycle. You will be given lab requisitions for these tests. The dose and timing of your chemotherapy may be changed based on your blood counts and / or other side effects. You may be given a prescription for anti-nausea medication (filled at your regular pharmacy) that you bring in each time for your treatment. Your nurse will tell you when to take the anti-nausea medication. It is easier to prevent nausea than to treat it once it has occurred, so follow directions closely. BC Cancer Agency Protocol Summary (Patient Version) HNNAVGEM 1/6

Treatment Protocol Cycle 1: Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Gemcitabine Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 Gemcitabine Day 15 Day 16 Day 17 Day 18 Day 19 Day 20 Day 21 No chemo This 21-day cycle will repeat 4 to 6 more times. What are the side effects of Gemcitabine, how often do they occur and how do I manage them? Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of as they are directly related to the common actions of the drugs in your treatment plan. SERIOUS SIDE EFFECTS Your white blood cells will decrease 1-2 weeks after your treatment. They usually return to normal within 1 week. White blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. How common is it? common MANAGEMENT To help prevent infection: Wash your hands often and always after using the bathroom. Take care of your skin and mouth. Avoid crowds and people who are sick. Call your doctor immediately at the first sign of an infection such as fever (over 100 F or 38 C by oral thermometer), chills, cough, or burning when you pass urine. BC Cancer Agency Protocol Summary (Patient Version) HNNAVGEM 2/6

SERIOUS SIDE EFFECTS Your platelets may decrease 1-2 weeks after your treatment. They usually return to normal within 1 week. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. Shortness of breath, or difficulty breathing, that is sudden in onset, may sometimes occur with gemcitabine. How common is it? common rare MANAGEMENT To help prevent bleeding problems: Try not to bruise, cut, or burn yourself. Clean your nose by blowing gently. Do not pick your nose. Avoid constipation. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Some medications such as ASA (e.g., ASPIRIN ) or ibuprofen (e.g., ADVIL ) may increase your risk of bleeding. Do not stop taking any medication that has been prescribed by your doctor (e.g., ASA for your heart). For minor pain, try acetaminophen (e.g., TYLENOL ) first, but occasional use of ibuprofen may be acceptable. Call your doctor immediately if you suddenly develop difficulty in breathing. Get Emergency help. BC Cancer Agency Protocol Summary (Patient Version) HNNAVGEM 3/6

OTHER SIDE EFFECTS How common is it? MANAGEMENT A flu-like illness may occur shortly after your treatment. You may have fever, chills, headache, muscle and joint aches. Flu-like symptoms usually disappear on their own. uncommon Take acetaminophen (e.g., TYLEONOL ) every 3-4 hours if needed. Fever and chills, which occur more than 48 hours after treatment, may be signs of an infection. They should be reported to the doctor immediately. Nausea and vomiting may occur after your treatment and may last for 24 hours. It is usually mild to moderate. very common See details above. You may be given a prescription for antinausea drug(s) to take before your chemotherapy treatment and/or at home. It is easier to prevent nausea than treat it once it has occurred, so follow directions closely. Drink plenty of fluids. Eat and drink often in small amounts. Try the ideas in Food Choices to Control Nausea. Skin rash may occur after treatment with gemcitabine. It is usually mild and is found on the arms, legs, chest, back or stomach. It may or may not be itchy. Tiredness and lack of energy may occur. common very common Apply hydrocortisone cream 0.5% sparingly 3-4 times daily. Do not drive a car or operate machinery if you are feeling tired. Try the ideas in Your bank of energy savings: How people with cancer can handle fatigue. BC Cancer Agency Protocol Summary (Patient Version) HNNAVGEM 4/6

OTHER SIDE EFFECTS How common is it? MANAGEMENT Diarrhea may occur. uncommon To help diarrhea: Drink plenty of fluids. Eat and drink often in small amounts. Avoid high fibre foods as outlined in Coping with Diarrhea. Hair loss sometimes occurs with gemcitabine. Your hair will grow back once you stop treatment. Colour and texture may change. Pain or tenderness may occur where the needle was placed. INSTRUCTIONS FOR THE PATIENT uncommon rare Use a gentle shampoo and soft brush. Care should be taken with use of hair spray, bleaches, dyes and perms. Apply cool compresses or soak in cool water for 15-20 minutes several times a day. What other drugs can interact with gemcitabine? Gemcitabine may increase the blood-thinning effect of warfarin (COUMADIN ). Inform your Family Doctor to check your INR during your treatment, and for 1 to 2 months after your treatment is finished. Adjust your warfarin dose as directed by your Doctor. Check with your doctor or pharmacist before you start taking any new prescription or non-prescription products. THE FOLLOWING INFORMATION IS VERY IMPORTANT SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Sign of an infection such as fever )over 100 F or 38 C by an oral thermometer); chills; cough; pain or burning when you pass urine. Signs of bleeding problems such as black, tarry stools; blood in urine; pinpoint red spots on skin. Signs of an allergic reaction soon after a treatment including dizziness, fast heart beat, face swelling or breathing problems. Signs of lung problems such as shortness of breath or difficulty breathing. Signs of heart problems such as fast or uneven heart beat. BC Cancer Agency Protocol Summary (Patient Version) HNNAVGEM 5/6

SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Signs of anemia such as unusual tiredness or weakness. Signs of liver problems such as yellow eyes, or skin, white or clay-coloured stools. Signs of kidney problems such as lower back or side pain, swelling of feet or lower legs, numbness or tingling in feet or hands, blood in urine or cloudy urine. CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE OR BOTHER YOU: Uncontrolled nausea, vomiting, constipation or diarrhea. Easy bruising or bleeding. Redness, swelling, pain or sores where the needle was placed. Skin rash with or without itching. Excessive drowsiness. Aches and pains. If you experience symptoms or changes in your body that have not been described above but worry you, or in any symptoms are severe, contact: at telephone number: BC Cancer Agency Protocol Summary (Patient Version) HNNAVGEM 6/6